Dr. Holly Marie Spanggord, MD

Dr. Spanggord practices at Pacific Hills Surgery Center in Laguna Hills, California.

Dr. Spanggord's NPI, 1346234465, was assigned on September 2, 2005. Dr. Spanggord graduated from UCSF School of Medicine in 1997. Dr. Spanggord's California license number on file is A77935.

Dr. Spanggord's primary practice is Pacific Hills Surgery Center, at 24022 Calle De La Plata, #180, Laguna Hills, CA 92653. The practice phone is (714) 458-3551.

Dr. Spanggord's primary practice is Pacific Hills Surgery Center in Laguna Hills, California. Dmand AI also links Dr. Spanggord to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spanggord practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Spanggord's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Spanggord is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Spanggord's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Spanggord treats.

CMS data shows 1,641 Medicare services from Dr. Spanggord across 15 procedure codes in 2024, for 707 Medicare patients. Medicare paid $139,119 for them.

CMS counts 707 Medicare patients who saw Dr. Spanggord in 2024. The largest group is 75 to 84, with 318 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spanggord's median patient age at 78, with 65% women.

In 2024, Dr. Spanggord wrote 2,850 Medicare Part D claims for 733 patients. 48% of them were for generic drugs. CMS names the drug for 2,720 of them, across 25 drugs with 11 or more claims each, at $802,193 in total drug cost. In 2023, CMS named 2,788 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Spanggord for performance year 2024, reported individually. Dr. Spanggord accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 71 procedures of cataract surgery by Dr. Spanggord, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Spanggord. Dr. Spanggord's most frequent co-author is Donna M. Ferriero.

CMS Open Payments shows 123 general payments to Dr. Spanggord from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Shire North American Group Inc paid the most, $796.

Dmand AI lists 2 awards for Dr. Spanggord, most recently CMS Stage 1 EHR in 2013.

Dr. Spanggord graduated from UCSF School of Medicine in 1997. Dr. Spanggord is a member of AAO.

Dr. Spanggord is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.